Concepedia

Payal Dhar

PD

Statistics

Publications

5

Citations

407

H-Index

5

Active since

2015

Affiliations

Medical University of South Carolina(Current)

Northwestern University

University of Miami

Neurological Surgery

Payal Dhar is an author at Medical University of South Carolina specializing in cancer immunotherapy, immunology, and oncology.

ORCID

Publications per year

2015–2021

5

Publications

5

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty et al. · Cell Metabolism · 2017 · 264 citations · Full text

, , +10

Anticancer activity of Ophiobolin A, isolated from the endophytic fungus <i>Bipolaris setariae</i>

Dimple Bhatia, Payal Dhar, Varun Mutalik et al. · Natural Product Research · 2015 · 47 citations

, , +14

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Fahmin Basher, Payal Dhar, Xin Wang et al. · Journal of Hematology & Oncology · 2020 · 42 citations · Full text

, , +17

Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy

Jinyu Zhang, Pablo Larrocha, Bin Zhang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 35 citations · Full text

, , +17

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation

Payal Dhar, Fahmin Basher, Zhe Ji et al. · Communications Biology · 2021 · 19 citations · Full text

, , +17

1–5 of 5